Myriad Genetics
MYGN
MYGN
239 hedge funds and large institutions have $2.12B invested in Myriad Genetics in 2017 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 74 increasing their positions, 88 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 233 → 239 (+6)
2.31% less ownership
Funds ownership: 123.04% → 120.73% (-2.3%)
16% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 88
Holders
239
Holding in Top 10
5
Calls
$18.8M
Puts
$14.1M
Top Buyers
| 1 | +$69.9M | |
| 2 | +$20.3M | |
| 3 | +$15.1M | |
| 4 |
PP
PDT Partners
New York
|
+$8.48M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$7.91M |
Top Sellers
| 1 | -$34.2M | |
| 2 | -$18.2M | |
| 3 | -$15.7M | |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$10.7M |
| 5 |
Renaissance Technologies
New York
|
-$10.3M |